This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
These include engineering the cells to express cytokines that promote their maturation and/or differentiation, and engineering drug-resistant γδ T cells that can be combined with chemotherapies, which stress cancer cells but would otherwise also deplete the T-cell population. and MBA students with real-world consulting experiences.
We believe our allogenic CAR-T platform is significantly stronger with chPD1 target licensed from Longwood University. The pipeline development is leveraged through the Company’s proprietary target discovery engine called “DIAMOND.” Amorette Barber of Longwood University will be heading up our chPD1 program.
Phage-based products have been licensed for use as antibacterial agents in the sanitation , food production , and animal health industries. Crucially, it could also make them easier to license as therapeutic agents. The resulting data are fed into an analytical engine that runs millions of simulations. aeruginosa, S. pneumoniae.
.” Wellcome Collection , London I wrapped up my series on “30 Days of Great Biology Papers.” ” This was a series of tweets in which I told brief stories behind seminal papers, mostly in molecularbiology and biophysics. You can read all of them here. I’ve written about this before. No longer.
.” Wellcome Collection , London I wrapped up my series on “30 Days of Great Biology Papers.” ” This was a series of tweets in which I told brief stories behind seminal papers, mostly in molecularbiology and biophysics. You can read all of them here. I’ve written about this before. No longer.
Dr Frederic Cedrone is the Vice President of Corporate Innovation at Catalent, where he works closely with the Cell and Gene Therapy teams to drive innovation in emerging therapeutic modalities through strategic partnerships, licensing and technology acquisitions.
Credit: Bruce Wetzel and Harry Schaefer, NCI, NIH | License Progress in biology is arguably moving faster today than at any point in the course of human history. Engineeredbiology has profound potential to change how we live, but the field has become broad, bloated, nebulous. Journal of MolecularBiology (1961).
The way we typically prepare white beans completely deactivates the mild toxin that could otherwise cause food poisoning, the highly venomous cone snail that produced that shell was long gone by the time you picked it up, and Botox has been safe to inject by licensed healthcare professionals since FDA approval in 1991.
Credit: Bruce Wetzel and Harry Schaefer, NCI, NIH | License Last edit: 13 September 2023 Progress in biology is arguably moving faster today than at any point in the course of human history. Engineeredbiology has profound potential to change how we live, but the field has become broad, bloated, nebulous. Nature (2005).
It could be similar to our prior article on Cultivarium (a non-profit building tools to engineer “weird” microbes). White Labs Inside a Synthetic Silk Factory A few different companies are making synthetic silk from engineered cells, including AMSilk, Spiber, and Bolt Threads. How are the cells engineered to make silk?
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content